GlassScriptPhysician profile
Scott Jeffery Alan Holbert
NPI 1639503923
$1,859.26
in general payments reported to CMS, 2019-2025
11 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $162 · 2021: $152 · 2022: $81.33 · 2023: $369 · 2024: $429 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Entertainment: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.29 |
| Entertainment | $112.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,331.58 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $213.65 | 2020-2025 | Dailies Total1, Dailies |
| Optos, INC. | $112.98 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $46.95 | 2019 | |
| Abb Con-Cise Optical Group LLC | $45.73 | 2019-2020 | |
| Oyster Point Pharma, INC. | $26.78 | 2024 | Tyrvaya |
| Plexus Optix, INC. | $23.41 | 2019 | |
| Abbvie INC. | $20.83 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Coopervision INC. | $12.67 | 2019 | |
| Visioneering Technologies, INC. | $7.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Holbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.